ArticleOncoTargets and therapy2020

Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three Cases.

Hongyu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.